Document Detail

Profile of interdialytic blood pressure in hemodialysis patients.
MedLine Citation:
PMID:  12481148     Owner:  NLM     Status:  MEDLINE    
BACKGROUND AND METHODS: Hypertension is a common problem in hemodialysis (HD). However, its behavior during the interdialytic period is not completely known and is infrequently monitored in clinical practice. Thus, for better understanding of interdialytic blood pressure (BP), we analyzed the interdialytic blood pressure profile using 44-hour ambulatory blood pressure monitoring (ABPM) data in 71 unselected, stable HD patients. RESULTS: There was an increase in BP during the interdialytic period (awake day 1: 135/84 +/- 23/14 mm Hg; awake day 2: 140/86 +/- 22/15 mm Hg, p < 0.05; sleep day 1: 130/77 +/- 24/15 mm Hg; sleep day 2: 136/80 +/- 24/15 mm Hg, p < 0.05). The correlation between the average 44-hour BP and interdialytic weight gain (IDWG) was not significant (r = -0.07 for systolic BP and r = -0.09 for diastolic BP). The number of non-dipper patients was high, 77% on interdialytic day 1 and 83% on interdialytic day 2 for systolic BP. Uncontrolled hypertension (average 44 h BP > or =135/85 mm Hg) was diagnosed in 58 (55%) patients. Patients with uncontrolled hypertension had higher pre- and posthemodialysis BP, higher BP on each interdialytic day and night, and higher night/day diastolic BP ratio on the second interdialytic day. These patients were also taking a greater number of vasoactive medications (1.5 vs. 0.6 in those with controlled BP, p = 0.001). There were no significant differences related to kt/V, hematocrit, or weekly erythropoietin dose between patients with controlled or uncontrolled BP. Hemodialysis shift assignment (morning or afternoon) did not impact on BP levels or diurnal profile. CONCLUSION: In HD patients, interdialytic BP is often poorly controlled, there is a progressive rise in BP, and a trend toward loss of nocturnal decline in BP as the interdialytic period progresses. Further research is needed to determine whether treatment directed to interdialytic BP changes can alter outcomes in HD patients.
Sergio F F Santos; Roger B Mendes; Carlos A Santos; David Dorigo; Aldo J Peixoto
Related Documents :
15311148 - Home-based self-measurement of blood pressure: a proposal using new reference values (t...
18568698 - Do screening blood pressure and plasma catecholamines predict development of hypertensi...
19963978 - Impedance cardiography for cuffless and non-invasive measurement of systolic blood pres...
15564988 - Telemonitoring of blood pressure self measurement in the olmetel study.
2091688 - Recombinant human erythropoietin and its effects on macro- and microcirculation during ...
21174218 - Primary versus secondary hypertension in children followed up at an outpatient tertiary...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  American journal of nephrology     Volume:  23     ISSN:  0250-8095     ISO Abbreviation:  Am. J. Nephrol.     Publication Date:    2003 Mar-Apr
Date Detail:
Created Date:  2002-12-13     Completed Date:  2003-05-27     Revised Date:  2007-02-14    
Medline Journal Info:
Nlm Unique ID:  8109361     Medline TA:  Am J Nephrol     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  96-105     Citation Subset:  IM    
Copyright Information:
Copyright 2003 S. Karger AG, Basel
Division of Nephrology, State University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antihypertensive Agents / pharmacology
Blood Pressure / drug effects,  physiology*
Blood Pressure Monitoring, Ambulatory*
Circadian Rhythm*
Kidney Failure, Chronic / physiopathology*,  therapy
Linear Models
Middle Aged
Renal Dialysis*
Time Factors
Weight Gain / drug effects,  physiology
Reg. No./Substance:
0/Antihypertensive Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effects of an acute dose of L-arginine during coronary angiography in patients with chronic renal fa...
Next Document:  Treatment of anemia with darbepoetin alfa administered de novo once every other week in chronic kidn...